| (210) | Number of the EPO application | 16814513 |
| (220) | Filing date of the EPO application | 2016.06.24 |
| (80) | EPO patent specification publication (B) | EPB nr. 37/2022, 2022.09.14 |
| (110) | EPO patent number | 3315131 |
| (21) | Number of the application | e 2018 0459 |
| (71) | Name(s) of applicant(s), code of the country | Taiho Pharmaceutical Co., Ltd., JP; |
| (72) | Name(s) of inventor(s), code of the country | FUJIOKA Akio, JP; |
| (73) | Name(s) of owner(s), code of the country | TAIHO Pharmaceutical Co. Ltd., JP; |
| (54) | Title of the invention | THERAPEUTIC AGENT FOR FIBROSIS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/47 (2006.01.01); A61P 11/00 (2006.01.01); C07D 215/50 (2006.01.01) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2018.06.30 |
| (30) | Priority | 2015127788, 2015.06.25, JP |
| (86) | International application | PCT/JP2016/068902, 2016.06.24 |
| (87) | International publication | WO 2016/208744, 2016.12.29 |